Key Record Dates
ClinicalTrials.gov Identifier: | NCT05282953 |
---|---|
Brief Title: | A Phase I/II Dose-escalating Study of the Safety, Tolerability and Efficacy of KIO-301 Administered Intravitreally to Patients With Retinitis Pigmentosa and Choroideremia (ABACUS) |
First Submitted : | March 8, 2022 |
First Submitted that Met QC Criteria : | March 15, 2022 |
First Posted : | March 16, 2022 |
Last Update Submitted that Met QC Criteria : | March 13, 2024 |
Last Update Posted : | March 15, 2024 |